https://www.selleckchem.com/pr....oducts/spop-i-6lc.ht
RESULTS We enrolled 15 patients in the study. The total dosages of basal insulin decreased significantly, but the total doses of bolus insulin did not change significantly. All the TIRs increased significantly by approximately 11.6%; the TBRs less then 70 mg/dL remained unchanged; and the mean glucose and SD decreased significantly, whereas the CVs did not. CONCLUSIONS SGLT2 inhibitors improved TIRs and the mean glucose levels and SDs without increasing the TBR less then 70 mg/dL in patients with type 1 diabetes. This article is prot
Like
Comment
Share
